Spyre Therapeutics Inc.Gewinn- und Verlustrechnung
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 102.13 USD | 105,09 USD | 14,505 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 103,933 USD | 10 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 86.841.253 | 16,81 | 7,57 |
Kennzahl in 1000 USD | TTM 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |